Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy STAAR Surgical Company stock | $142.84
Learn how to easily invest in STAAR Surgical Company stock.
STAAR Surgical Company is a medical instruments & supplies business based in the US. STAAR Surgical Company shares (STAA) are listed on the NASDAQ and all prices are listed in US Dollars. STAAR Surgical Company employs 575 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in STAAR Surgical Company
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – STAA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- STAA shares summary
- Compare share dealing platforms
- Is STAA stock a buy or sell?
- Stock performance over time
- Can I short STAA shares?
- Are STAA shares over-valued?
- STAAR Surgical Company's financials
- How volatile are STAA shares?
- Does STAAR Surgical Company pay a dividend?
- Have STAA shares ever split?
- Other common questions
STAAR Surgical Company stock price (NASDAQ: STAA)Use our graph to track the performance of STAA stocks over time.
STAAR Surgical Company shares at a glance
|Latest market close||$142.84|
|52-week range||$45.47 - $161.71|
|50-day moving average||$143.79|
|200-day moving average||$118.44|
|Wall St. target price||$140.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.22|
Buy STAAR Surgical Company shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy STAAR Surgical Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
STAAR Surgical Company price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||-6.33%|
|3 months (2021-04-30)||4.26%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Is STAAR Surgical Company under- or over-valued?
Valuing STAAR Surgical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STAAR Surgical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STAAR Surgical Company's P/E ratio
STAAR Surgical Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 604x. In other words, STAAR Surgical Company shares trade at around 604x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
STAAR Surgical Company's EBITDA
STAAR Surgical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.5 million.
The EBITDA is a measure of a STAAR Surgical Company's overall financial performance and is widely used to measure a its profitability.
STAAR Surgical Company financials
|Revenue TTM||$179 million|
|Operating margin TTM||9.14%|
|Gross profit TTM||$119.6 million|
|Return on assets TTM||4.33%|
|Return on equity TTM||5.82%|
|Market capitalisation||$6.3 billion|
TTM: trailing 12 months
Shorting STAAR Surgical Company shares
There are currently 1.6 million STAAR Surgical Company shares held short by investors – that's known as STAAR Surgical Company's "short interest". This figure is 12.7% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting STAAR Surgical Company shares can be evaluated.
STAAR Surgical Company's "short interest ratio" (SIR)
STAAR Surgical Company's "short interest ratio" (SIR) is the quantity of STAAR Surgical Company shares currently shorted divided by the average quantity of STAAR Surgical Company shares traded daily (recently around 421647.66839378). STAAR Surgical Company's SIR currently stands at 3.86. In other words for every 100,000 STAAR Surgical Company shares traded daily on the market, roughly 3860 shares are currently held short.
However STAAR Surgical Company's short interest can also be evaluated against the total number of STAAR Surgical Company shares, or, against the total number of tradable STAAR Surgical Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STAAR Surgical Company's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 STAAR Surgical Company shares in existence, roughly 30 shares are currently held short) or 0.043% of the tradable shares (for every 100,000 tradable STAAR Surgical Company shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against STAAR Surgical Company.
Find out more about how you can short STAAR Surgical Company stock.
STAAR Surgical Company share dividends
We're not expecting STAAR Surgical Company to pay a dividend over the next 12 months.
Have STAAR Surgical Company's shares ever split?
STAAR Surgical Company's shares were split on a 1:2 basis on 17 May 1992. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STAAR Surgical Company shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for STAAR Surgical Company shares which in turn could have impacted STAAR Surgical Company's share price.
STAAR Surgical Company share price volatility
Over the last 12 months, STAAR Surgical Company's shares have ranged in value from as little as $45.47 up to $161.71. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STAAR Surgical Company's is 0.9782. This would suggest that STAAR Surgical Company's shares are less volatile than average (for this exchange).
STAAR Surgical Company overview
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Stocks similar to STAAR Surgical Company
STAAR Surgical Company in the news
Staar Surgical (STAA) Earnings Expected to Grow: Should You Buy?
Were Hedge Funds Right About STAAR Surgical Company (STAA)?
Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week
Frequently asked questionsWhat percentage of STAAR Surgical Company is owned by insiders or institutions?
Currently 0.691% of STAAR Surgical Company shares are held by insiders and 92.982% by institutions. How many people work for STAAR Surgical Company?
Latest data suggests 575 work at STAAR Surgical Company. When does the fiscal year end for STAAR Surgical Company?
STAAR Surgical Company's fiscal year ends in January. Where is STAAR Surgical Company based?
STAAR Surgical Company's address is: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630 What is STAAR Surgical Company's ISIN number?
STAAR Surgical Company's international securities identification number is: US8523123052 What is STAAR Surgical Company's CUSIP number?
STAAR Surgical Company's Committee on Uniform Securities Identification Procedures number is: 852312305
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert